Skip to main content
ORATOR2 mute on best de-escalation therapy for low-risk HPV+ oropharynx cancers
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
ORATOR2 mute on best de-escalation therapy for low-risk HPV+ oropharynx cancers
User login
Username
Password
Reset your password
Concept
Lead
score
Head and Neck Cancer
1
1
Otolaryngology
0
0.9
Surgery
0
0.82
Head and Neck Surgery
0
0.67
Robotic Surgery
0
0.63
Cancer
0
0.34
Human Papillomavirus
0
0.99
Cervical Region
0
0.29
Biologic Therapy
0
0.27
Neck Dissection
0
0.27
Squamous Cell Carcinoma
0
0.27
Toxicology
0
0.26
Quality of Life
0
0.19
Canada
0
0.15
Grant
0
0.15
Anatomy
0
0.1
Healthcare and Medical Technology
0
0.1
Biomedical Technology
0
0.05
Board Certification
0
0.05
Clinical Research
0
0.05
Cough
0
0.05
Europe
0
0.05
Infarction
0
0.05
Mechanical Ventilation
0
0.05
Myocardial Infarction (MI)
0
0.05
Papillomavirus
0
0.05
Radiation Therapy
0
0.05
Tracheostomy
0
0.05
Tumor
0
0.05
Weight Loss
0
0.05
Weight Management
0
0.05
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
0.9
Edit Tags